Stay updated on ADCT-602 for B-cell ALL: Clinical Trial
Sign up to get notified when there's something new on the ADCT-602 for B-cell ALL: Clinical Trial page.

Latest updates to the ADCT-602 for B-cell ALL: Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check25 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check32 days agoChange DetectedThe clinical trial ADCT-602 for treating patients with recurrent or refractory B-cell acute lymphoblastic leukemia has been updated to reflect a new date of May 16, 2025, replacing the previous date of November 27, 2024.SummaryDifference1%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check68 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. Additionally, a phrase has been removed and replaced with a similar one, but the core content remains unchanged.SummaryDifference1.0%
Stay in the know with updates to ADCT-602 for B-cell ALL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADCT-602 for B-cell ALL: Clinical Trial page.